A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer

Author： Zaghloul Mohamed   Boutrus Rimoun   El-Hossieny Hisham   Kader Yasser   El-Attar Inas   Nazmy Mohamed  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.15, Iss.4, 2010-08, pp. : 382-389

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Chen B, Zoledronic Acid Prostate Cancer Study Group, Uro-Oncology Clinic, Centre Hospitalier de l'Universite, de Montreal, Hopital Notre-Dame, Montreal, Quebec, Canada - J Natl Cancer Inst 2002;94:1458-1468

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 408-408

Elsevier

Access to resources Recommend Favorite

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

By Miles David   Baselga José   Amadori Dino   Sunpaweravong Patrapim   Semiglazov Vladimir   Knott Adam   Clark Emma   Ross Graham   Swain Sandra  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 89-99

Springer Publishing Company

Access to resources Recommend Favorite

Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial

By Guo Ying   Jones Desiree   Palmer J.   Forman Arthur   Dakhil Shaker   Velasco Maria   Weiss Matthias   Gilman Paul   Mills G.   Noga Stephen   Eng Cathy   Overman Michael   Fisch Michael  

Supportive Care in Cancer, Vol. 22, Iss. 5, 2014-05 ,pp. : 1223-1231

Springer Publishing Company

Access to resources Recommend Favorite

Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer

By Eatock M. M.   Tebbutt N. C.   Bampton C. L.   Strickland A. H.   Valladares-Ayerbes M.   Swieboda-Sadlej A.   Van Cutsem E.   Nanayakkara N.   Sun Y.-N.   Zhong Z. D.   Bass M. B.   Adewoye A. H.   Bodoky G.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 710-718

Oxford University Press

Access to resources Recommend Favorite

L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: A double-blind, randomized, placebo-controlled trial

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 33-39

Spandidos Publications

Access to resources Recommend Favorite